{"id":23523,"date":"2024-05-07T10:25:17","date_gmt":"2024-05-07T08:25:17","guid":{"rendered":"https:\/\/mabdesign.fr\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/"},"modified":"2024-05-07T10:25:17","modified_gmt":"2024-05-07T08:25:17","slug":"ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/","title":{"rendered":"AGS Therapeutics Strengthens its Patent Portfolio on MicroalgaeExtracellular Vesicles (MEVs) with an International PatentApplication on the use of MEVs to deliver biological agents to thebrain by the intranasal route of administration."},"content":{"rendered":"\n<p>PARIS, FRANCE, May 7, 2024 \u2013 AGS Therapeutics, a preclinical-stage biotech company pioneering microalgae extracellular vesicles (MEV) as a new, universal delivery system, announced the recent publication of its PCT International Application No. PCT\/EP2023\/078634 \u2013 Publication &#8211; WO 2024\/088808, titled Extracellular Vesicles from Microalgae, their Biodistribution upon Intranasal Administration, and Uses Thereof.<br>Thanks to their rare and natural capacity to overcome certain stringent biological barriers, MEVs can be used to deliver payloads to tissues and organs which have been so far either difficult or impossible to access by current alternative systems like LNPs, viral gene therapy vectors, or mammalian EVs. The blood-brain-barrier (BBB), a natural obstacle that protects the brain from agents arriving from the blood, is a canonical example of such stringent barriers. So much so, that efforts to overcome the BBB have consumed focus and large amounts of ressources for decades, and continue doing so today. <a href=\"http:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/05\/AGS-PR-Patent-PCT-publication-MAY-7-2024.pdf\">To know more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AGS Therapeutics, a preclinical-stage biotech company pioneering microalgae extracellular vesicles (MEV) as a new, universal delivery system, announced the recent publication of its PCT International Application No. PCT\/EP2023\/078634 \u2013 Publication &#8211; WO 2024\/088808, titled Extracellular Vesicles from Microalgae, their Biodistribution upon Intranasal Administration, and Uses Thereof.<\/p>\n","protected":false},"author":3,"featured_media":23522,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36,32],"tags":[],"class_list":["post-23523","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-our-members"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>AGS Therapeutics Strengthens its Patent Portfolio on MicroalgaeExtracellular Vesicles (MEVs) with an International PatentApplication on the use of MEVs to deliver biological agents to thebrain by the intranasal route of administration. - MabDesign<\/title>\n<meta name=\"description\" content=\"AGS Therapeutics, a preclinical-stage biotech company pioneering microalgae extracellular vesicles (MEV) as a new, universal delivery system, announced the recent publication of its PCT International Application No. PCT\/EP2023\/078634 \u2013 Publication - WO 2024\/088808, titled Extracellular Vesicles from Microalgae, their Biodistribution upon Intranasal Administration, and Uses Thereof.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AGS Therapeutics Strengthens its Patent Portfolio on MicroalgaeExtracellular Vesicles (MEVs) with an International PatentApplication on the use of MEVs to deliver biological agents to thebrain by the intranasal route of administration. - MabDesign\" \/>\n<meta property=\"og:description\" content=\"AGS Therapeutics, a preclinical-stage biotech company pioneering microalgae extracellular vesicles (MEV) as a new, universal delivery system, announced the recent publication of its PCT International Application No. PCT\/EP2023\/078634 \u2013 Publication - WO 2024\/088808, titled Extracellular Vesicles from Microalgae, their Biodistribution upon Intranasal Administration, and Uses Thereof.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-07T08:25:17+00:00\" \/>\n<meta name=\"author\" content=\"Laure Delhon\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Laure Delhon\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/\"},\"author\":{\"name\":\"Laure Delhon\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/e7f929f9c28647aff12061d31ac44f39\"},\"headline\":\"AGS Therapeutics Strengthens its Patent Portfolio on MicroalgaeExtracellular Vesicles (MEVs) with an International PatentApplication on the use of MEVs to deliver biological agents to thebrain by the intranasal route of administration.\",\"datePublished\":\"2024-05-07T08:25:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/\"},\"wordCount\":178,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/05\/1648045790625.jpeg\",\"articleSection\":[\"News\",\"Our members\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/\",\"name\":\"AGS Therapeutics Strengthens its Patent Portfolio on MicroalgaeExtracellular Vesicles (MEVs) with an International PatentApplication on the use of MEVs to deliver biological agents to thebrain by the intranasal route of administration. - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/05\/1648045790625.jpeg\",\"datePublished\":\"2024-05-07T08:25:17+00:00\",\"description\":\"AGS Therapeutics, a preclinical-stage biotech company pioneering microalgae extracellular vesicles (MEV) as a new, universal delivery system, announced the recent publication of its PCT International Application No. PCT\/EP2023\/078634 \u2013 Publication - WO 2024\/088808, titled Extracellular Vesicles from Microalgae, their Biodistribution upon Intranasal Administration, and Uses Thereof.\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/#primaryimage\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/05\/1648045790625.jpeg\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/05\/1648045790625.jpeg\",\"width\":200,\"height\":200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AGS Therapeutics Strengthens its Patent Portfolio on MicroalgaeExtracellular Vesicles (MEVs) with an International PatentApplication on the use of MEVs to deliver biological agents to thebrain by the intranasal route of administration.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/e7f929f9c28647aff12061d31ac44f39\",\"name\":\"Laure Delhon\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/066cd19881c24784247d7cba92fef00a9cef88209b15a463ee495ac0fc2ba664?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/066cd19881c24784247d7cba92fef00a9cef88209b15a463ee495ac0fc2ba664?s=96&d=mm&r=g\",\"caption\":\"Laure Delhon\"},\"url\":\"https:\/\/mabdesign.fr\/en\/author\/laure-delhonmabdesign-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AGS Therapeutics Strengthens its Patent Portfolio on MicroalgaeExtracellular Vesicles (MEVs) with an International PatentApplication on the use of MEVs to deliver biological agents to thebrain by the intranasal route of administration. - MabDesign","description":"AGS Therapeutics, a preclinical-stage biotech company pioneering microalgae extracellular vesicles (MEV) as a new, universal delivery system, announced the recent publication of its PCT International Application No. PCT\/EP2023\/078634 \u2013 Publication - WO 2024\/088808, titled Extracellular Vesicles from Microalgae, their Biodistribution upon Intranasal Administration, and Uses Thereof.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/","og_locale":"en_US","og_type":"article","og_title":"AGS Therapeutics Strengthens its Patent Portfolio on MicroalgaeExtracellular Vesicles (MEVs) with an International PatentApplication on the use of MEVs to deliver biological agents to thebrain by the intranasal route of administration. - MabDesign","og_description":"AGS Therapeutics, a preclinical-stage biotech company pioneering microalgae extracellular vesicles (MEV) as a new, universal delivery system, announced the recent publication of its PCT International Application No. PCT\/EP2023\/078634 \u2013 Publication - WO 2024\/088808, titled Extracellular Vesicles from Microalgae, their Biodistribution upon Intranasal Administration, and Uses Thereof.","og_url":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/","og_site_name":"MabDesign","article_published_time":"2024-05-07T08:25:17+00:00","author":"Laure Delhon","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"Laure Delhon","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/"},"author":{"name":"Laure Delhon","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/e7f929f9c28647aff12061d31ac44f39"},"headline":"AGS Therapeutics Strengthens its Patent Portfolio on MicroalgaeExtracellular Vesicles (MEVs) with an International PatentApplication on the use of MEVs to deliver biological agents to thebrain by the intranasal route of administration.","datePublished":"2024-05-07T08:25:17+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/"},"wordCount":178,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/05\/1648045790625.jpeg","articleSection":["News","Our members"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/","url":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/","name":"AGS Therapeutics Strengthens its Patent Portfolio on MicroalgaeExtracellular Vesicles (MEVs) with an International PatentApplication on the use of MEVs to deliver biological agents to thebrain by the intranasal route of administration. - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/#primaryimage"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/05\/1648045790625.jpeg","datePublished":"2024-05-07T08:25:17+00:00","description":"AGS Therapeutics, a preclinical-stage biotech company pioneering microalgae extracellular vesicles (MEV) as a new, universal delivery system, announced the recent publication of its PCT International Application No. PCT\/EP2023\/078634 \u2013 Publication - WO 2024\/088808, titled Extracellular Vesicles from Microalgae, their Biodistribution upon Intranasal Administration, and Uses Thereof.","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/#primaryimage","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/05\/1648045790625.jpeg","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/05\/1648045790625.jpeg","width":200,"height":200},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-strengthens-its-patent-portfolio-on-microalgaeextracellular-vesicles-mevs-with-an-international-patentapplication-on-the-use-of-mevs-to-deliver-biological-agents-to-thebrain-by-the\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"AGS Therapeutics Strengthens its Patent Portfolio on MicroalgaeExtracellular Vesicles (MEVs) with an International PatentApplication on the use of MEVs to deliver biological agents to thebrain by the intranasal route of administration."}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/e7f929f9c28647aff12061d31ac44f39","name":"Laure Delhon","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/066cd19881c24784247d7cba92fef00a9cef88209b15a463ee495ac0fc2ba664?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/066cd19881c24784247d7cba92fef00a9cef88209b15a463ee495ac0fc2ba664?s=96&d=mm&r=g","caption":"Laure Delhon"},"url":"https:\/\/mabdesign.fr\/en\/author\/laure-delhonmabdesign-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/23523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=23523"}],"version-history":[{"count":0,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/23523\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media\/23522"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=23523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=23523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=23523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}